1 Followers
24 Following
debranbano

debranbano

Does Medical Cannabis Help To Cure Parkinson’s Disease

It is known as a neurodegenerative disease of the CNS, Parkinson affects approximately 6 million people around the world, most of them more than 60. Nobody knows why this starts. There may be a genetic bias, but the possible causes of exposure to pesticides and severe head injuries are also the primary and possible causes.

 

The symptoms come gradually over time and are commonly linked with the motor system, like moving, hardness, slow-motion movement, or shuffle. But they can also be followed by emotional and cognitive disturbances as well as with sleeping difficulties.

 

Signs Of Parkinson’s Disease

 

The early symptoms of Parkinson's disease are;

 

  • A person may feel the increased level of anxiety, fear, and depression. He also feels lonely
  • Increase sexual dysfunction, severe pain and aches, and sweating
  • Imbalance
  • Frequent constipation and loss of bladder
  • Slurred or slow speech
  • Tremors
  • Slow movement
  • The problem in writing skills
  • An increased risk of choking.
  • Hallucinations happen at the early stage of Parkinson's disease. A decline in intellectual ability
  • Cause cognitive problems (dementia)
  • Tremors
  • The slow movement (bradykinesia)
  • Sleep disturbance during the day

Parkinson’s Patients Turn To Cannabis

 

It is common that people who are living with Parkinson's and their families are hopeless to slow down the disease and increase the life's limited symptoms, look at other options.

It's been twenty years that scientists have begun to know how cannabis affects the body after the determination of the endocannabinoid system - chemicals such as homeostatic regulatory receptors (CB 1 and CB2) and cannabis, the network is included, mainly developed in the CNS and immune system and brain.

 

So, CBD oil is a better option to treat a Parkinson’s, if it’s legal to your country. It is available in the Medical dispensary of Canada.

 

Parkinson’s Disease And The Endocannabinoid System

 

One of the significant roles of the endocannabinoid system (ECS), is controlling the life of a cell, is crucial in the CNS where it is hard to remove brain cell loss individually.

 

Scientists have realized that in neurodegenerative disease, ECS may also have a neuroprotective effect, as shown by alters in endocannabinoid levels and receptor expression. While these ECS changes are open for interpretation, the conclusion is that they reflect the body is struggling to decrease against neuronal damage resulting from the disease.

 

Researchers have already indicated that plant cannabinoids may have a direct effect on the endocannabinoid system. It is no wonder that cannabinoids are used as a medical device in an exciting area of research in coping with the neurodegenerative disease.

 

Parkinson’s And CBD

 

The CBD is usually a problematic cannabinoid to understand because there is a poorly binding relationship with endocannabinoid receptors. Most of its medicinal effects come from its interactions with other non-ECS receptors, as well as blocking the enzyme, which makes the metabolism a major endocannabinoid in the body.

 

When it comes to Parkinson's and CBD, the compound has been shown to block CB1 receptor activity, which has a particular interest in researching Parkinson's.

 

Which CBD Oil Is Best For The Parkinson’s Disease?

 

The secret to your decision must find the CBD oils extracted from Organic Hemp by using state-of-the-art supercritical CO2 methods. This assures that CBD is free of oil solvents and active compounds such as terpenes and cannabinoids are stored.

 

Always ask to see the laboratory report related to CBD oil that you want to purchase. The only way to know how many CBDs you are getting and to make sure that the product has no lousy chemistry, heavy metal or mold.

 

CBD Oil Treat Parkinson’s Disease – Final Thought

 

Although there are still early days in the field of CBD oil research for Parkinson, the initial results look better. And as soon as more clinical trials occur, science will eventually catch up with those patients who are already experienced.